Journal for ImmunoTherapy of Cancer (Nov 2021)
89 The immune marker LAG-3 increases the predictive value of CD38+ immune cells for survival outcome in immunotherapy-treated hepatocellular carcinoma
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2021)